Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of cobas HCV GT against Versant HCV Genotype 2.0 (LiPA) with confirmation by Sanger sequencing.

Journal of virological methods - 1 May 2018

Yusrina Falah, Chua Cui Wen, Lee Chun Kiat, Chiu Lily, Png Tracy Si-Yu, Khoo Mui Joo, Yan Gabriel, Lee Guan Huei, Yan Benedict, Lee Hong Kai

Abstract excerpt

BACKGROUND: Correct identification of infecting hepatitis C virus (HCV) genotype is helpful for targeted antiviral therapy. OBJECTIVES: Here, we compared the HCV genotyping performance of the cobas HCV GT assay against the Versant HCV Genotype 2.0 (LiPA) assay, using 97 archived serum samples. STUDY DESIGN: In the event of discrepant or indeterminate results produced by either assay, the core and NS5B regions...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genotype
Share to Genotyping Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Hepatitis C

Share to Phylogeny

Share to Real-Time Polymerase Chain Reaction

Share to RNA, Viral

Share to Sequence Analysis, DNA

Source

Identifiers

PMID: 29428399
DOI: 10.1016/j.jviromet.2018.02.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of cobas HCV GT against Versant HCV Genotype 2.0 (LiPA) with confirmation by Sanger sequencing.PMID 29428399Read ↗

The cobas® HCV GT is a new tool that accurately identifies Hepatitis C virus genotypes for clinical practice.Semantic proximity Read ↗

Comparison of three different HCV genotyping methods: core, NS5B sequence analysis and line probe assay.Semantic proximity Read ↗

Evaluation of Versant hepatitis C virus genotype assay (LiPA) 2.0.Semantic proximity Read ↗

Sequencing assays for failed genotyping with the versant hepatitis C virus genotype assay (LiPA), version 2.0.Semantic proximity Read ↗

Performance of 6 HCV genotyping 9G test for HCV genotyping in clinical samples.Semantic proximity Read ↗

Diagnosis of hepatitis C virus genotype 2k/1b needs NS5B sequencing.Semantic proximity Read ↗

Comparison of Abbott RealTime HCV Genotype II with Versant Line Probe Assay 2.0 for Hepatitis C Virus GenotypingSemantic proximity Read ↗

Comparative performance of two commercial sample-to-result systems for hepatitis C virus quantitation and genotyping.Semantic proximity Read ↗

A novel standardized deep sequencing-based assay for hepatitis C virus genotype determination.Semantic proximity Read ↗

Evaluation of the Abbott RealTime HCV genotype II plus RUO (PLUS) assay with reference to core and NS5B sequencing.Semantic proximity Read ↗

Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan analyte-specific reagent assay and comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 assays.Semantic proximity Read ↗

NS3 genomic sequencing and phylogenetic analysis as alternative to a commercially available assay to reliably determine hepatitis C virus subtypes 1a and 1b.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.